BR0207445A - Métodos e composições para tecido de ligação cruzada - Google Patents

Métodos e composições para tecido de ligação cruzada

Info

Publication number
BR0207445A
BR0207445A BR0207445-1A BR0207445A BR0207445A BR 0207445 A BR0207445 A BR 0207445A BR 0207445 A BR0207445 A BR 0207445A BR 0207445 A BR0207445 A BR 0207445A
Authority
BR
Brazil
Prior art keywords
methods
tissue
bridges
compositions
crosslinking
Prior art date
Application number
BR0207445-1A
Other languages
English (en)
Inventor
Matthew F Ogle
M William Ii Mirsch
Original Assignee
St Jude Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Medical filed Critical St Jude Medical
Publication of BR0207445A publication Critical patent/BR0207445A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODOS E COMPOSIçõES PARA TECIDO DE LIGAçãO CRUZADA". O tecido é ligado de forma cruzada para conectar dois ou mais dos ligantes. Em algumas modalidades, as pontes conectam dois ou mais sítios modificados em um tecido modificado. O uso de pontes nos métodos de ligação cruzada modifica mais sítios em um tecido modificado. O uso de pontes nos métodos de ligação cruzada forma mais facilmente ligações cruzadas, particularmente entre polipeptídeos diferentes no tecido. O uso de pontes pode permitir maiores modulações no nível de ligação cruzada do tecido.
BR0207445-1A 2001-03-12 2002-03-11 Métodos e composições para tecido de ligação cruzada BR0207445A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/804,408 US20020177223A1 (en) 2001-03-12 2001-03-12 Methods and compositions for crosslinking tissue
PCT/US2002/007349 WO2002072165A1 (en) 2001-03-12 2002-03-11 Methods and compositions for crosslinking tissue

Publications (1)

Publication Number Publication Date
BR0207445A true BR0207445A (pt) 2004-04-06

Family

ID=25188902

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207445-1A BR0207445A (pt) 2001-03-12 2002-03-11 Métodos e composições para tecido de ligação cruzada

Country Status (5)

Country Link
US (1) US20020177223A1 (pt)
EP (1) EP1368072A1 (pt)
BR (1) BR0207445A (pt)
CA (1) CA2440087A1 (pt)
WO (1) WO2002072165A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201771B2 (en) 2001-12-27 2007-04-10 Arbor Surgical Technologies, Inc. Bioprosthetic heart valve
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US7556647B2 (en) 2003-10-08 2009-07-07 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
US20050244460A1 (en) * 2004-04-29 2005-11-03 Ivan Alferiev Biodegradable crosslinking strategies using triglycidyl amine (TGA)
US8445278B2 (en) 2005-03-01 2013-05-21 Medtronic, Inc. Process for producing decellularized biological tissues
US7513909B2 (en) 2005-04-08 2009-04-07 Arbor Surgical Technologies, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
WO2006130505A2 (en) 2005-05-27 2006-12-07 Arbor Surgical Technologies, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
WO2007130881A2 (en) 2006-04-29 2007-11-15 Arbor Surgical Technologies, Inc. Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them
US20080171906A1 (en) * 2007-01-16 2008-07-17 Everaerts Frank J L Tissue performance via hydrolysis and cross-linking
US9682173B2 (en) * 2008-06-11 2017-06-20 The Children's Mercy Hospital Solutions for tissue engineering and methods of use
US20100104608A1 (en) * 2008-09-26 2010-04-29 Tyco Healthcare Group Lp Reactive surgical implant
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
US20100111919A1 (en) * 2008-10-31 2010-05-06 Tyco Healthcare Group Lp Delayed gelation compositions and methods of use
WO2011053713A1 (en) * 2009-10-29 2011-05-05 Depuy Products, Inc. Methods of making crosslinked polymeric material for orthopaedic implants
CN102284083B (zh) * 2011-07-07 2013-12-18 中山大学 一种细胞外基质的改性方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4883864A (en) * 1985-09-06 1989-11-28 Minnesota Mining And Manufacturing Company Modified collagen compound and method of preparation
US4729139A (en) * 1985-11-05 1988-03-08 Baxter Travenol Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
US4798611A (en) * 1986-10-14 1989-01-17 Hancock Jaffe Laboratories Enhancement of xenogeneic tissue
US4813964A (en) * 1986-10-14 1989-03-21 Hancock Jaffe Laboratories Crosslinked anisotropic xenogeneic diaphragm tissue in flexor tendon pulley reconstruction
US5147514A (en) * 1987-08-02 1992-09-15 University Of North Carolina Process for cross-linking collagenous material and resulting product
US4976733A (en) * 1988-02-03 1990-12-11 Biomedical Design, Inc. Prevention of prosthesis calcification
US5660692A (en) * 1988-02-24 1997-08-26 Cedars-Sinai Medical Center Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers
US5336616A (en) * 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5104405A (en) * 1991-02-21 1992-04-14 The University Of Southern California Process for improving the biostability of tissue implant devices and bioprosthetic implants so produced
US5571216A (en) * 1994-01-19 1996-11-05 The General Hospital Corporation Methods and apparatus for joining collagen-containing materials
US5447536A (en) * 1994-02-17 1995-09-05 Biomedical Design, Inc. Method for fixation of biological tissue
US6203755B1 (en) * 1994-03-04 2001-03-20 St. Jude Medical, Inc. Electron beam sterilization of biological tissues
US5616689A (en) * 1994-07-13 1997-04-01 Collagen Corporation Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
US5549666A (en) * 1994-09-02 1996-08-27 Baxter International Inc. Natural tissue valve prostheses having variably complaint leaflets
US5674298A (en) * 1994-10-21 1997-10-07 The Board Of Regents Of The University Of Michigan Calcification-resistant bioprosthetic tissue and methods of making same
AU692330B2 (en) * 1994-12-30 1998-06-04 National University Of Singapore, The Method for reducing calcification of biological tissue used in implantable bioprostheses
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5865849A (en) * 1995-06-07 1999-02-02 Crosscart, Inc. Meniscal heterografts
US5869274A (en) * 1995-08-09 1999-02-09 Zymed Laboratories, Inc. Immuno-histochemical method that reduces background staining
US6049025A (en) * 1995-09-15 2000-04-11 Stone; Kevin R. Articular cartilage xenografts
AU717660B2 (en) * 1995-12-18 2000-03-30 Angiodevice International Gmbh Crosslinked polymer compositions and methods for their use
JP2000506050A (ja) * 1996-03-04 2000-05-23 バクスター・インターナショナル・インコーポレイテッド 生物学的組織を架橋するための非ポリマー性エポキシ化合物およびそれにより調製される生体補綴移植片
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
EP0829724A1 (en) * 1996-09-17 1998-03-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Assay for detecting collagen degradation
US6013106A (en) * 1997-01-22 2000-01-11 St. Jude Medical, Inc. Medical article with adhered antimicrobial metal ions and related methods
CA2279625C (en) * 1997-02-10 2008-01-29 Biomedical Design, Inc. Sterilization of organs and prostheses with coupling agents
US5934283A (en) * 1997-04-15 1999-08-10 Uroplasty, Inc. Pubovaginal sling device
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
US5958669A (en) * 1997-05-02 1999-09-28 St. Jude Medical, Inc. Apparatus and method for crosslinking to fix tissue or crosslink molecules to tissue

Also Published As

Publication number Publication date
EP1368072A1 (en) 2003-12-10
WO2002072165A1 (en) 2002-09-19
CA2440087A1 (en) 2002-09-19
US20020177223A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
BR0207445A (pt) Métodos e composições para tecido de ligação cruzada
BR9911621A (pt) Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina
ATE344241T1 (de) Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosine kinasesn, insbesondere von raf kinasen
BR0206985A (pt) Anticorpos modificados e métodos de uso
EE9700310A (et) N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine
CY2014034I2 (el) Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης
ES2162231T3 (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen afinidad con los receptores de bradicinina.
NO20011575L (no) Substituerte 3-cyanokinoliner som proteintyrosin-kinase- inhibitorer
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
EA199800913A1 (ru) Кальцилитические соединения
BR0110968A (pt) Antagonistas dos receptores de il-8
DE69934241D1 (de) Agonistische antikörper gegen tie2
PT918774E (pt) Compostos moduladores do receptor para androgenio e metodos
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
EA200000351A1 (ru) Лечение кондуктивных нарушений
ES2202855T3 (es) Uso de antagonistas 5ht3 para promover el lavado intestinal.
DE69908501D1 (de) Polymerdispersionen
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
BR0314053A (pt) Pirazolopiridinas e métodos de obtenção e uso das mesmas
BR0214157A (pt) Mantas não-tecidas tendo uniformidade de constrição aperfeiçoada
BR9909486A (pt) Compostos calcilìticos
DZ2700A1 (fr) Indoles 2,3-substitués servant d'agents anti-inflammatoires et analgésiques.
DE60009888T2 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
EA199900912A1 (ru) Фармацевтические средства
AR016981A2 (es) Polipeptidos sinteticos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]